Optibrium Launches Online Community for Drug Optimisation
News Nov 23, 2009
The Optibrium community will also provide a forum for the wider drug discovery community to discuss approaches to drug optimisation and share ideas and best practices aimed at improving the productivity of drug discovery.
The Optibrium community site includes interactive forums covering topics such as drug design and optimisation, as well as the application of StarDrop to challenges in drug discovery projects. Articles and presentations by the Optibrium team and the wider community are accessible to everyone and available for comment by community members. Additional predictive QSAR models and scripts that extend the functionality of StarDrop can also be downloaded. Furthermore, access to technical support and FAQs through the community site will bring the Optibrium team even closer to our user base and allow StarDrop users to learn from others’ experience.
Ed Champness, CSO of Optibrium, commented “We are excited by this latest development which will bring together our hundreds of users worldwide and help them to get the most out of StarDrop. We also believe that this will be a stimulating environment for discussion of wider issues and solutions to the challenges of quickly and efficiently discovering new drug candidates.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE